For information about supplements that have been investigated in humans for athletic performance and joint health, see our Reviews of Muscle and Workout Supplements , Collagen Supplements , Nitric Oxide Supplements , and Joint Health Supplements
These agents are FDA-approved primarily for the management of type 2 diabetes mellitus and, for specific products (Wegovy, Saxenda, Zepbound), for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
No regulatory body Health Canada, the FDA, the EMA, the TGA, or any equivalent has approved BPC-157 as a drug for human or veterinary use
Results in one model may not translate to another
Since April 2026, BPC-157 sits on the FDA's 503A Category 2 list